Market Research Logo

Global Acne Treatment Market: Trends and Opportunities (2014-2019)

Global Acne Treatment Market: Trends and Opportunities (2014-2019)

Scope of the Report

The report titled “Global Acne Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the acne market with focus on global prescription drugs. The report assesses the market sizing and growth of the global acne market, the growth of acne market in various regions and the growth and composition of oral and topical acne drugs. The report further analyzes the major prescription drugs for the treatment of acne. The report also discusses key factors driving growth of the industry, major trends and challenges faced by manufacturers of acne drugs. Further, key players like Foamix Pharmaceuticals, Valeant Pharmaceuticals, Dermira and Actavis Plc are analyzed in the report.

Product Coverage

Anti-Acne Drugs

Regional Coverage

United States
Asia Pacific

Company Coverage

Foamix Pharmaceuticals HELLA
Valeant Pharmaceuticals
Actavis Plc

Executive Summary

The global acne market represents a small fraction of total dermatology market and both over the counter drugs and prescription drugs are used to treat acne. The acne market is primarily genericised and is moderately served by the currently marketed major prescribed drugs including SOLODYN, DORYX, and EPIDUO. The US market is the largest market for the global acne products with about 50 million suffering from acne in the country.

Globally, acne market is of very small size but holds immense potential driven mostly by growing income of individuals, rising health expenditures, increased fast food consumption and increased spending on drugs from various emerging economies. The acne market is also characterized by immense research and development opportunities. New laser treatment for acne, technology driven products are the key trends of the acne industry. However, with immense growth opportunities, the global acne market faces the challenges in terms of high prices of drugs, regulatory issues, increased competition from new drugs and lastly the adverse effects of drugs.

1. Executive Summary
2. Acne Treatment Market: An Overview
2.1 Introduction
2.1.1 Causes for Acne Vulgaris
2.2 Types of Acne
Table A: Types of Acnes based on Severity
2.3 Acne Treatment
Table 1: Acne Treatment Paradigm
2.3.1 Product Classes Used to Treat Acne
2.3.2 Prescription Drugs or Retinoid
3. Global Acne Treatment Market: An Analysis
3.1 Global Acne Market- Size and Growth
Table 2: Global Acne Market Size, (In US$ Billions), 2009-2013
Table 3: Global Acne Market Size - Forecast (In US$ Billions), 2014-2019
3.2 Global Acne Market Split
4. Acne Treatment Market: Product Analysis
4.1 Global Prescription Drugs
4.1.1 SOLODYNTM (Minocycline Hydrochloride)
Table 4: Penetration of Total U.S. Minocycline Market v/s SOLODYN, 2012-2019
Table 5: SOLODYN Worldwide Sales, (In US$ Millions), 2010-2011
4.1.2 DORYX (Doxycycline Heclate)
Table 6: DORYX Worldwide Sales, (In US$ Millions), 2010-2011
Table 7: DORYX US Market Share (In percent), (Jan 2014- April 2014)
4.1.3 EPIDUO (ADAPALENE .1%, Benzoyl Peroxide 2.5%)
Table 8: EPIDUO Worldwide Sales, (In US$ Millions), 2010-2011
Table 9: Preferred Topical Therapy
Table 10: ABSORICA Growing Market Penetration in the US, Nov-12-Nov-14
4.1.5 ACZONE
Table 11: ACZONE Worldwide Sales (In US$ Millions), 2010-2011
4.2 Over the Counter Products (OTC)
Table B: Common OTC Products for Acne Treatment
4.3 Dermatology Market
Table 12: Global Dermatology Market Size, (In US$ Billion), 2009-2014E
5. Acne Treatment Market: Regional Analysis
5.1 United States
Table 13: Segmentation of the U.S. Acne Market
Table 14: US Oral Prescription Drugs Split for Acne Drugs – Reimbursement by Payor Type, 2013
Table 15: US Branded Topical Prescription Drugs Split for Acne Drugs – Reimbursement by Payor Type, 2013
Table C: Acne Prevalence by Age and Gender in US
Table 16: US Market Share of Oral Brands – Anti-Acne Market
Table 17: US Market Share of Topical Brands – Anti-Acne Market
5.2 European Union
Table 18: Acne Treatment with Self-medication in Europe's main markets
5.3 Asia Pacific
Table 19: Anti-Acne Market in Asia Pacific (In US$ Millions), 2009-2013
Table 20: Anti-Acne Market in Asia Pacific – Forecast (In US$ Millions), 2014-2019
5.4 Japan
Table 21: OTC Acne Treatment Product Sales in Japan, (US$ Million), 2009-2013
6. Acne Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Households Income
Table 22: Forecasted number of high-income households (Millions), 2013-2019
6.1.2 Rising Healthcare Expenditures
Table 23: Global Healthcare Expenditures per Capita, (US$ Millions), 2007-2013
6.1.3 Rising Fast Food Industry
Table 24: Forecasted Fast Food Industry (US$ Billions), 2013-2019
6.1.4 Patent Expiry
Table D: Acne Treatment - Drugs Patent Expiry Dates
6.1.5 Rising Spending from Emerging Economies
Table 25: Annual spending on Medicines in Emerging Economies V/S Developed
6.2 Market Trends
6.2.1 Increased Focus on Combination Therapies
6.2.2 New laser treatment for acne
6.2.3 Technology‐driven products
6.2.4 Safety concerns on current drugs
6.2.5 Efficacy concerns on current drugs
6.3 Market Challenges
6.3.1 Adverse Effects of Drugs
6.3.2 High Cost of Acne Drugs
6.3.3 Regulatory Issues
6.3.4 Increased Competition
7. Competitive Landscape: Acne Treatment Market
Table E: Acne Treatment - Prescription Drugs comparison
8. Company Analysis: Acne Treatment Market
8.1 Foamix Pharmaceuticals Ltd.
8.1.1 Business Description
Table F: Foamix Acne Product versus Valeant Acne Product
8.1.2 Financial Overview
Table 26: Forecasted FMX101 U.S. Acne Sales, (US$ Million), 2017-2019
8.1.3 Business Strategies
8.2 Valeant Pharmaceuticals
8.2.1 Business Description
Table 27: Sales Contribution of Dermatological Subclasses to Valeant
8.2.2 Financial Overview
Table 28: Revenue of Valeant Pharmaceuticals International, (In US$ Billions),
8.2.3 Business Strategies
Table G: Valeant 2014 expected launches in Dermatology/ Aesthetics
8.3 Dermira
8.3.1 Business Description
Table H: Important Dermira Product Categories
8.3.2 Financial Overview
Table 29: Expected Revenue of Dermira (US$ Millions), 2015-2019
Table I: Analysis of Dermira’s DRM01 for Acne
Table J: Dermira’s Valuation Compared to Other Early Stage Company
8.3.3 Business Strategies
8.4 Actavis Plc
8.4.1 Business Description
Table K: Actavis Specialty Brands Research and Development
8.4.2 Financial Overview
Table 30: Actavis Net Revenue, (US$ Millions), 2010 - 2013
8.4.3 Business Strategies
Table 31: DORYX TRx (In 1000 TRx) (Jan 2012- Dec 2013)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report